Balchem Records 18% Revenue Growth In Q4, Tops Consensus
Balchem Corp (NASDAQ:BCPC) reported fourth-quarter FY21 sales growth of 17.9% year-on-year, to $213.13 million, beating the consensus of $198.17 million. Sales from Human Nutrition and Health segment rose 11.3% Y/Y to $115.5 million, Animal Nutrition and Health increased 27.7% to $65 million, and Specialty Products grew 12.3% to $27.4 million. Adjusted EPS of…
Benzinga ·
Benzinga
